alopecia areata: Loss of scalp and body hair involving microscopically inflammatory patchy areas.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1178 |
4. Check minimum number of eventsNone |
1178 |
5. Include endpointsNone |
1178 |
6. Filter based on genotype QC (FinnGen only) |
1076 |
Control definitions (FinnGen only)
- Control exclude
- L12_DISORDSKINAPPENDIX
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- L60-L75
- Name in latin
- Alopecia areata
Similar endpoints
↥List of similar endpoints to
Alopecia areata
based on the number of shared cases.
Similar with more cases:
- Disorders of skin appendages
- Autoimmune diseases
- Used for control exclusion in common control thyroid runs
- Diseases of the skin and subcutaneous tissue
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 7560 | 5187 | 2341 |
| Only index persons | 7028 | 4903 | 2125 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.12 | 0.15 | 0.07 |
| Only index persons | 0.15 | 0.18 | 0.08 |
| Median age at first event (years) | |||
| Whole population | 32.57 | 36.09 | 24.73 |
| Only index persons | 33.86 | 37.07 | 26.45 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1076 | 855 | 221 |
| Unadjusted period prevalence (%) | 0.26 | 0.30 | 0.10 |
| Median age at first event (years) | 44.98 | 45.04 | 44.71 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1125
- Matched controls
- 11250
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L63.8
ICD-10 Finland
Other alopecia areata
2700.2
307.7
472
*
L63.9
ICD-10 Finland
Alopecia areata, unspecified
961.8
307.7
570
12
L63.0
ICD-10 Finland
Alopecia (capitis) totalis
+∞
196.8
183
*
S23
ICPC
Hair loss/baldness
37.2
195.5
123
37
D07AD01
ATC
clobetasol; topical
5.8
170.4
433
1096
L63
ICD-10 Finland
Alopecia areata
203.9
155.1
158
9
D07AC01
ATC
betamethasone; topical
4.6
137.7
679
2818
L63.1
ICD-10 Finland
Alopecia universalis
1403.5
130.9
125
*
D07AC13
ATC
mometasone; topical
4.0
113.8
550
2178
L65.9
ICD-10 Finland
Nonscarring hair loss, unspecified
32.7
81.7
53
17
D07AB02
ATC
hydrocortisone butyrate; topical
2.5
47.5
452
2363
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.9
44.9
145
411
70400
ICD-8 Finland
Diseases of hair and hair follicles, Alopecia areata (benigna, maligna)
+∞
43.0
41
*
L64.9
ICD-10 Finland
Androgenic alopecia, unspecified
95.9
42.1
46
5
E0000UV, ,
ATC
2.3
42.1
589
3601
TQW80
NOMESCO Finland
Local dermatologic skincare
7.3
41.4
62
89
XQ802
NOMESCO Finland
Epicutan test
4.6
40.9
103
242
D07AA02
ATC
hydrocortisone; topical
2.6
36.5
248
1085
H02AB06
ATC
prednisolone; systemic
2.2
34.7
588
3786
L20.0
ICD-10 Finland
Besnier prurigo
2.8
30.0
164
637
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.7
27.7
165
669
D07AB08
ATC
desonide; topical
2.6
26.3
168
705
XQ845
NOMESCO Finland
Dermatoscopy
7.2
25.6
38
54
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.6
23.5
155
659
L04AD01
ATC
ciclosporin; systemic
6.0
23.2
41
70
D07XC01
ATC
betamethasone; topical
2.5
22.8
153
655
L04AA01
ATC
[U] ciclosporin
8.3
22.7
30
37
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.0
22.1
290
1639
E000001, ,
ATC
2.0
20.7
266
1489
E000002, ,
ATC
2.3
19.6
163
767
XQ848
NOMESCO Finland
Dermatological photography
4.7
18.8
44
97
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
2.0
18.8
263
1511
L64.8
ICD-10 Finland
Other androgenic alopecia
182.8
17.6
18
*
D02AE01
ATC
carbamide; topical
2.7
17.2
93
357
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
2.1
16.8
174
894
317
Kela drug reimbursment
Topical pimecrolimus and tacrolimus
4.4
16.0
40
93
C03DA01
ATC
spironolactone; oral
2.4
15.8
120
542
D11AH01
ATC
tacrolimus; topical
6.0
15.8
28
48
XQ800
NOMESCO Finland
Prick test
2.3
14.6
112
507
69100
ICD-8 Finland
Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum
5.0
14.1
30
61
L65.8
ICD-10 Finland
Other specified nonscarring hair loss
30.4
13.9
18
6
D06BX01
ATC
metronidazole; topical
2.1
13.6
131
651
L04AX03
ATC
methotrexate; systemic
2.2
13.6
124
603
R06AX22
ATC
ebastine; oral
1.8
13.5
227
1370
D11AH02
ATC
pimecrolimus; topical
13.0
13.4
23
18
H04.10
ICD-10 Finland
Dry eye syndrome
2.0
13.3
159
857
E000003, ,
ATC
2.8
13.1
65
238
R06AE07
ATC
cetirizine; oral
1.6
13.1
539
4113
L04AX01
ATC
azathioprine; systemic
3.0
12.7
58
203
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
12.7
455
3352
H03AA01
ATC
levothyroxine sodium; systemic
1.7
12.6
284
1860
70401
ICD-8 Finland
Diseases of hair and hair follicles, Alopecia alia sive NUD
+∞
12.5
12
*
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.9
12.3
172
976
WXQ27
NOMESCO Finland
UVB narrow spectrum light therapy
5.4
11.9
23
43
L71.8
ICD-10 Finland
Other rosacea
9.4
11.5
23
25
E000006, ,
ATC
2.3
11.5
87
392
7040B
ICD-9 Finland
Diseases of hair and hair follicles, Alopecia[ALOPECIA AREATA]
+∞
11.5
11
*
L70.0
ICD-10 Finland
Acne vulgaris
3.5
11.3
38
110
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.6
11.2
447
3349
D02AX
ATC
Other emollients and protectives
3.0
11.1
48
163
D11AX14
ATC
[U] tacrolimus
10.2
11.0
21
21
D05AX52
ATC
calcipotriol, combinations; topical
2.6
11.0
62
243
J05AB01
ATC
aciclovir; systemic
1.7
10.8
261
1733
L20.9
ICD-10 Finland
Atopic dermatitis, unspecified
2.6
10.7
64
259
R06AX27
ATC
desloratadine; oral
1.6
10.6
382
2792
L66.9
ICD-10 Finland
Cicatricial alopecia, unspecified
111.0
10.4
11
*
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.0
10.3
124
669
L71.9
ICD-10 Finland
Rosacea, unspecified
3.8
10.2
31
84
H02AB04
ATC
methylprednisolone; systemic
1.8
10.0
152
885
L04AA06
ATC
mycophenolic acid; systemic
4.0
9.6
27
69
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
4.4
9.6
24
56
D11AX15
ATC
[U] pimecrolimus
15.2
9.5
15
10
L90.0
ICD-10 Finland
Lichen sclerosus et atrophicus
2.7
9.5
52
201
H01.0
ICD-10 Finland
Blepharitis
2.0
9.5
99
507
P01BA02
ATC
hydroxychloroquine; oral
2.1
9.4
97
494
L65.2
ICD-10 Finland
Alopecia mucinosa
+∞
9.4
9
*
J01AA04
ATC
lymecycline; systemic
1.8
9.0
153
919
UJF32
NOMESCO Finland
Coloscopy
1.6
9.0
241
1634
127
Kela drug reimbursment
Transplant complication
4.4
8.9
22
51
L30.8
ICD-10 Finland
Other specified dermatitis
3.0
8.8
39
135
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.7
8.7
195
1263
E000007, ,
ATC
2.2
8.7
71
331
D07AC14
ATC
methylprednisolone aceponate; topical
2.4
8.7
59
254
D07AB01
ATC
clobetasone; topical
2.8
8.6
43
159
S24
ICPC
Hair/scalp symptom/complaint other
4.1
8.3
22
54
A07AA02
ATC
nystatin; oral
2.3
8.2
64
292
J45.9
ICD-10 Finland
Asthma, unspecified
1.6
8.2
208
1390
R03AC02
ATC
salbutamol; inhalant
1.4
8.0
630
5289
WZC00, ,
SPAT
1.7
7.8
172
1109
104
Kela drug reimbursment
Thyroid insufficiency
2.1
7.8
78
394
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.6
7.7
203
1368
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.7
7.6
143
885
J02AC02
ATC
itraconazole; systemic
1.6
7.6
186
1232
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.5
7.6
318
2369
K50.1
ICD-10 Finland
Crohn disease of large intestine
4.3
7.5
19
45
L66.1
ICD-10 Finland
Lichen planopilaris
80.6
7.4
8
*
134
Kela drug reimbursment
General erythroderma
13.5
7.4
12
9
N05BB01
ATC
hydroxyzine; systemic
2.0
7.4
76
388
WZA10
NOMESCO Finland
Extensive medical or dental certificate
3.8
7.4
22
59
L80
ICD-10 Finland
Vitiligo
6.9
7.3
17
25
L01BA01
ATC
methotrexate; systemic
2.7
7.3
39
150
R5110, ,
SPAT
1.9
7.2
87
470
R01AD09
ATC
mometasone; nasal
1.4
7.2
529
4356
A02BC02
ATC
pantoprazole; systemic
1.4
7.2
689
5938
J01DA01
ATC
[U] cefalexin
1.4
7.1
646
5511
L73.8
ICD-10 Finland
Other specified follicular disorders
8.8
7.1
14
16
L93.0
ICD-10 Finland
Discoid lupus erythematosus
10.1
7.0
13
13
L21.9
ICD-10 Finland
Seborrhoeic dermatitis, unspecified
3.4
7.0
24
71
M13.9
ICD-10 Finland
Arthritis, unspecified
1.9
6.9
82
440
L43.8
ICD-10 Finland
Other lichen planus
3.6
6.9
22
62
J01AA02
ATC
doxycycline; systemic
1.4
6.8
797
7081
L71.0
ICD-10 Finland
Perioral dermatitis
3.2
6.7
26
83
E03.80
ICD-10 Finland
Hypothyroidism caused by autoimmune thyroiditis
2.7
6.6
35
134
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.9
6.6
85
470
SPAT1229
SPAT
Assessment of need for aid
2.1
6.6
62
307
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
2.0
6.5
74
391
L30.3
ICD-10 Finland
Infective dermatitis
2.5
6.5
40
165
A07EC01
ATC
sulfasalazine; oral, rectal
1.9
6.5
83
458
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
1.9
6.4
73
388
A01AB09
ATC
miconazole; local oral
1.8
6.3
87
491
S01GX01
ATC
cromoglicic acid; ophthalmic
1.5
6.3
247
1807
L63.2
ICD-10 Finland
Ophiasis
+∞
6.3
6
*
L20
ICD-10 Finland
Atopic dermatitis
2.2
6.2
48
219
L26
ICD-10 Finland
Exfoliative dermatitis
26.8
6.2
8
*
D07BC01
ATC
betamethasone and antiseptics; topical
1.7
6.2
111
676
J05AB11
ATC
valaciclovir; oral
1.6
6.2
161
1078
N03AX16
ATC
[U] pregabalin
1.5
6.2
211
1501
326
Kela drug reimbursment
Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)
3.8
6.1
18
48
6918B
ICD-9 Finland
Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[ECZEMA ATOPICUM]
4.1
6.1
16
39
R50.9
ICD-10 Finland
Fever, unspecified
1.6
6.0
158
1060
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.4
6.0
266
1990
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
76
67
12.09
73.97
1.1
1.5
22.49
25.78
umol/l
0.28
68
61
460
2840
2.05
28.78
1.6
1.4
2.12
1.88
u/ml
0.09
139
752
127
453
3.03
27.01
2.3
1.9
6.30
6.91
iu/ml
0.10
32
95
122
434
3.03
26.04
1.3
1.2
1.20
1.25
u/ml
—
8
33
88
260
3.59
25.37
1.3
1.2
1.73
6.75
u/ml
—
7
14
199
959
2.31
22.86
1.2
1.2
137.14
143.61
u/ml
0.10
82
377
96
322
3.17
22.61
1.4
1.2
2.00
2.83
u/ml
—
8
28
95
323
3.12
21.86
1.5
1.3
3.07
8.71
u/ml
0.74
15
46
99
345
3.05
21.84
1.4
1.2
3.53
29.32
u/ml
—
7
16
889
7296
2.04
20.85
6.0
4.2
11.01
10.63
mm/h
0.37
850
6869
378
2470
1.80
17.90
1.9
1.5
2.17
2.24
g/l
0.44
256
1555
696
5416
1.75
17.66
3.5
3.2
91.37
90.13
ug/l
0.08
657
5110
955
8221
2.07
17.07
6.2
4.7
14.92
14.54
pmol/l
5.26
904
7678
722
5786
1.69
15.38
11.4
9.4
3.92
3.98
e9/l
0.38
658
5063
160
828
2.09
15.04
1.7
1.3
564.25
222.89
u/ml
1.58
154
781
375
2545
1.71
15.01
2.5
2.2
2.52
2.71
mg/l
1.17
339
2195
88
360
2.57
14.31
2.4
1.7
1.18
1.21
g/l
0.41
83
340
602
4655
1.63
14.27
3.0
2.5
77.84
75.89
nmol/l
1.04
552
4295
591
4553
1.63
14.19
8.3
7.2
1.21
1.22
mmol/l
0.36
501
3953
184
1049
1.90
13.05
2.2
2.1
358.78
380.04
nmol/l
0.84
171
983
70
271
2.69
12.72
1.4
1.2
9.70
45.57
u/ml
—
7
28
516
3970
1.55
11.61
5.8
4.9
36.45
36.48
g/l
0.04
492
3753
439
3282
1.55
11.08
3.2
3.3
2.35
2.36
mmol/l
1.12
399
3021
29
71
4.17
10.92
2.6
3.1
—
—
—
0
0
35
100
3.58
10.65
1.1
1.1
78.20
48.00
u/ml
—
5
6
1024
9376
2.03
10.57
7.4
5.6
1.83
1.83
mu/l
0.02
980
8855
234
1526
1.67
10.33
2.6
2.4
13.61
14.06
umol/l
0.44
223
1425
512
4011
1.51
10.14
2.1
2.0
96.80
97.36
pmol/l
0.10
269
2089
517
4062
1.50
10.07
7.7
6.6
1.22
1.22
mmol/l
0.04
477
3761
139
816
1.80
8.85
4.7
3.0
10.39
10.44
g/l
0.05
133
757
265
1848
1.57
8.75
1.6
1.7
447.89
41841701.14
pmol/l
2.45
223
1575
121
690
1.84
8.47
2.3
2.4
0.53
0.42
e6/l
0.17
112
650
210
1397
1.62
8.44
2.5
2.4
2.44
2.39
g/l
0.59
199
1299
53
221
2.47
8.34
2.4
1.5
—
—
—
0
0
385
2933
1.48
8.31
5.6
3.7
0.01
0.01
estimate
0.03
165
1055
192
1268
1.62
7.91
2.6
2.5
22.56
23.47
%
0.46
181
1189
247
1745
1.53
7.58
2.8
2.6
2.43
2.44
mmol/l
0.36
219
1574
392
3049
1.44
7.40
3.7
2.5
55.03
61.15
u/l
1.50
371
2831
333
2513
1.46
7.38
1.7
1.6
20.11
20.95
nmol/l
0.48
285
2168
820
7310
1.45
6.93
10.4
7.6
78.72
77.45
u/l
0.37
799
6948
24
72
3.38
6.85
2.5
3.3
223.81
204.65
e6/l
0.22
16
62
69
351
2.03
6.78
1.8
1.5
0.02
0.28
iu/ml
—
10
48
350
2717
1.42
6.51
2.6
2.1
142.35
189.35
u/l
0.97
333
2588
21
61
3.49
6.30
2.1
3.6
962.10
775.20
u/ml
0.29
21
61
270
2013
1.45
6.23
3.5
2.5
7.18
7.84
e6/l
0.25
251
1831
34
133
2.60
6.16
3.1
3.2
0.86
1.35
%
0.54
29
121
284
2143
1.44
6.13
1.4
1.3
19.67
29.02
iu/ml
1.84
84
635
215
1542
1.49
6.03
3.3
2.5
112.90
110.46
ug/g
0.06
175
1232
31
118
2.67
5.93
1.4
1.2
—
—
—
0
0
22
69
3.23
5.89
2.4
3.4
513.23
494.09
e6/l
0.07
13
56
639
5534
1.36
5.88
5.6
5.1
6.66
6.45
mmol/l
1.09
599
5147
112
697
1.67
5.80
5.1
3.3
1.23
1.23
mmol/l
0.60
99
596
634
5506
1.35
5.61
4.9
3.7
0.02
0.29
estimate
0.48
170
1057
458
3792
1.35
5.55
10.5
10.3
1.12
1.14
inr
0.65
387
3124
629
5468
1.34
5.46
5.0
3.6
7.46
2.63
estimate
0.28
174
1110
15
29
5.23
5.40
1.2
1.5
91.80
100.52
%
0.44
15
29
38
168
2.31
5.35
5.0
2.4
8.89
7.79
pmol/l
0.36
38
168
185
1325
1.47
5.19
1.6
1.7
1184.88
1200.78
nmol/l
0.07
144
1005
109
695
1.63
5.15
3.4
4.2
75.77
75.23
ng/l
0.03
94
619
44
213
2.11
5.00
2.0
1.5
—
—
—
0
0
18
56
3.25
4.90
1.2
1.4
33.50
19.38
u/ml
—
6
8
204
1505
1.43
4.89
4.3
3.9
0.83
0.82
mmol/l
0.20
196
1431
111
723
1.59
4.82
1.7
1.4
—
—
—
0
0
15
42
3.61
4.77
1.5
4.4
45.67
135.52
umol/l
—
6
27
256
1981
1.38
4.64
1.4
1.3
18.02
9.66
u/ml
0.80
108
781
615
5416
1.30
4.47
5.0
3.6
0.00
0.00
estimate
0.50
167
1100
58
323
1.84
4.46
1.1
1.1
12.58
7.10
eliau/ml
—
6
51
101
660
1.58
4.34
1.2
1.3
107.57
35.55
au/ml
—
6
53
393
3273
1.31
4.30
3.7
3.3
43.88
43.76
ng/l
0.00
257
2000
153
1099
1.45
4.22
4.8
4.4
33.49
32.03
%
0.94
110
762
30
134
2.27
4.18
1.3
1.6
25.57
25.54
ng/l
0.00
30
134
949
8926
1.40
4.11
6.3
5.5
38.44
38.20
mmol/mol
0.35
898
8469
42
218
1.96
4.01
6.3
6.1
109.20
341.64
iu/ml
—
5
22
25
105
2.41
4.00
1.5
1.2
—
—
—
0
0
361
2998
1.30
3.98
3.8
3.1
27.40
75.82
e6/l
1.20
294
2244
98
650
1.56
3.96
3.4
2.6
66.41
66.86
g/l
0.21
90
606
277
2221
1.33
3.93
3.0
3.1
1189.72
825.81
ng/l
0.57
235
1848
36
178
2.06
3.93
2.1
1.5
—
—
—
0
0
563
4953
1.27
3.91
7.5
6.2
10.40
10.79
umol/l
0.35
543
4709
974
9220
1.42
3.91
5.1
4.5
5.73
5.76
mmol/l
0.30
905
8614
290
2353
1.31
3.76
1.9
2.0
1.07
1.04
mg/l
0.07
221
1791
136
979
1.44
3.71
6.3
5.9
—
—
—
0
0
105
719
1.51
3.69
2.3
2.4
22.84
20.69
au/ml
—
10
80
1025
9817
1.50
3.65
18.9
13.4
19.21
21.38
mg/l
1.45
858
7906
171
1291
1.38
3.57
2.4
2.7
28.73
29.35
s
0.99
166
1256
30
144
2.11
3.55
1.6
1.4
—
—
—
0
0
793
7318
1.28
3.54
3.6
3.5
—
—
—
0
0
476
4143
1.26
3.49
5.2
3.4
0.22
0.03
estimate
0.54
141
915
107
747
1.48
3.43
3.4
3.4
4.48
4.59
pmol/l
0.69
102
662
284
2325
1.30
3.42
3.1
2.6
324.11
319.17
umol/l
0.37
251
2083
24
107
2.27
3.40
1.2
1.1
—
—
—
0
0
719
6572
1.26
3.40
5.5
4.3
35.67
2508.10
e6/l
—
6
83
124
895
1.43
3.35
5.5
4.9
220.70
251.38
u/l
1.72
116
857
20
84
2.41
3.24
3.7
3.2
54.70
55.68
%
0.08
15
74
93
639
1.50
3.24
2.0
1.6
—
—
—
0
0
8
15
5.36
3.19
1.1
1.1
—
—
—
0
0
31
158
1.99
3.16
1.3
1.2
—
373.33
—
0
12
22
98
2.27
3.14
1.3
1.2
—
—
—
0
0
10
25
4.03
3.09
1.1
1.2
—
—
—
0
0
179
1396
1.34
3.04
2.1
1.9
—
—
—
0
0
16
63
2.56
2.96
1.3
1.2
—
—
—
0
0
22
101
2.20
2.94
1.4
1.3
5.72
2.34
u/ml
0.26
11
49
22
102
2.18
2.88
1.3
1.2
—
—
—
0
0
22
102
2.18
2.88
1.3
1.2
—
—
—
0
0
307
2589
1.26
2.85
3.7
3.0
0.22
0.39
e6/l
1.15
241
1852
151
1159
1.35
2.85
7.4
6.1
1.07
1.06
mmol/l
0.27
146
1073
1014
9762
1.39
2.80
19.2
14.9
139.58
139.66
mmol/l
0.54
1001
9578
1008
9696
1.38
2.78
5.8
5.2
2.80
2.80
mmol/l
0.01
946
9172
27
138
1.98
2.77
2.2
1.6
—
—
—
0
0
48
294
1.66
2.76
1.6
1.3
—
—
—
0
0
46
279
1.68
2.74
3.1
3.2
24.03
24.80
mmol/l
0.85
46
274
21
98
2.16
2.72
1.5
1.7
63.50
56.16
%
0.40
16
64
12
40
3.02
2.70
1.5
1.2
—
—
—
0
0
12
40
3.02
2.70
1.5
1.2
—
—
—
0
0
118
879
1.38
2.69
8.8
9.9
5.23
5.12
kpa
0.67
112
852
118
879
1.38
2.69
8.7
9.9
11.91
12.66
kpa
1.03
112
853
21
99
2.14
2.66
1.2
1.2
—
—
—
0
0
1061
10313
1.51
2.62
15.1
11.0
24.69
25.17
u/l
0.61
1042
10063
399
3491
1.22
2.60
4.0
3.3
31.29
29.67
u/l
0.27
382
3313
33
185
1.81
2.59
2.1
1.5
—
—
—
0
0
116
868
1.38
2.58
8.8
10.0
0.98
0.97
mmol/l
0.01
103
726
358
3102
1.23
2.56
3.7
3.4
7.43
7.65
mmol/l
0.40
305
2690
5
7
7.17
2.55
1.4
1.3
—
—
—
0
0
27
143
1.91
2.52
1.5
1.2
—
—
—
0
0
10
31
3.25
2.52
1.1
1.0
—
—
—
0
0
997
9600
1.34
2.50
5.4
4.6
4.74
4.75
mmol/l
0.14
940
9112
283
2397
1.24
2.50
4.9
3.6
1.02
1.65
kg/l
0.50
190
1584
1013
9778
1.36
2.50
19.3
15.0
3.94
3.93
mmol/l
0.63
999
9569
15
63
2.40
2.47
1.0
1.1
1836.47
1505.25
miu/ml
0.37
15
63
1100
10799
1.84
2.41
27.9
20.6
268.50
260.17
e9/l
4.52
1095
10623
6
12
5.02
2.40
1.5
1.0
—
—
—
0
0
37
220
1.71
2.40
1.4
1.4
—
—
—
0
0
19
90
2.13
2.39
1.6
1.5
0.67
1.16
promille
0.82
13
73
9
27
3.35
2.39
1.1
1.1
—
—
—
0
0
1100
10804
1.82
2.33
27.8
20.6
4.50
4.50
e12/l
0.02
1093
10605
276
2348
1.23
2.33
1.6
1.5
—
—
—
0
0
9
28
3.23
2.31
2.4
1.3
8.89
8.04
ug/l
—
9
28
9
28
3.23
2.31
1.1
1.2
—
—
—
0
0
1100
10806
1.81
2.30
27.8
20.6
6.73
6.73
e9/l
0.02
1093
10600
316
2731
1.22
2.28
5.0
4.1
8.61
15.04
mg/mmol
0.45
190
1678
64
441
1.48
2.27
2.0
1.8
—
—
—
0
0
35
210
1.69
2.22
1.5
1.6
133.13
141.10
au/ml
—
8
64
966
9291
1.28
2.22
16.5
12.3
86.20
87.58
ml/min/173m2
1.25
896
8476
10
36
2.79
2.14
2.4
1.9
58.36
79.57
ug/l
—
10
36
23
123
1.89
2.12
1.4
1.4
—
—
—
0
0
944
9066
1.26
2.11
4.6
3.9
1.21
1.25
mmol/l
1.31
890
8492
351
3085
1.20
2.11
4.3
3.0
0.01
0.04
estimate
0.50
148
903
8
25
3.22
2.09
1.3
1.1
—
—
—
0
0
23
124
1.87
2.08
1.4
1.4
—
—
—
0
0
21
110
1.93
2.06
1.5
1.6
—
—
—
0
0
70
502
1.42
2.04
1.6
1.4
—
—
—
0
0
26
147
1.79
2.03
1.2
1.2
—
—
—
0
0
12
50
2.42
2.03
1.3
1.1
—
—
—
0
0
8
26
3.09
2.01
1.0
1.1
—
—
—
0
0
8
26
3.09
2.01
1.3
1.1
—
—
—
0
0
753
7091
1.19
1.98
3.8
3.3
39.93
41.11
u/l
0.19
720
6762
28
164
1.73
1.96
2.5
1.8
—
—
—
0
0
140
1124
1.28
1.95
8.5
7.8
104.28
104.33
mmol/l
0.05
140
1124
64
456
1.43
1.94
1.4
1.5
—
—
—
0
0
5
11
4.56
1.94
2.6
2.1
59.54
84.44
ng/l
—
5
5
8
27
2.98
1.94
5.8
5.3
—
—
—
0
0
1059
10349
1.40
1.90
22.3
16.3
71.75
70.39
umol/l
1.10
1051
10239
37
236
1.59
1.89
4.4
3.2
47.46
59.30
mg/l
0.16
31
201
37
236
1.59
1.89
4.4
3.2
25.12
49.13
mg/l
0.98
31
199
38
244
1.58
1.89
2.0
2.7
4.10
7.12
umol/l
1.52
25
185
40
260
1.56
1.89
2.2
1.7
—
—
—
0
0
9
34
2.66
1.86
1.4
1.2
—
—
—
0
0
9
34
2.66
1.86
1.4
1.2
—
—
—
0
0
30
182
1.67
1.86
1.3
1.2
190.21
192.21
iu/ml
—
9
38
52
360
1.47
1.84
2.5
2.2
4.44
18.60
iu/l
0.48
21
160
41
270
1.54
1.84
3.4
5.9
8.90
8.56
kpa
0.69
41
263
5
12
4.18
1.82
1.2
1.3
—
—
—
0
0
5
12
4.18
1.82
1.6
1.0
—
—
—
0
0
19
101
1.90
1.81
2.3
1.9
—
—
—
0
0
112
885
1.29
1.78
4.3
2.9
—
—
—
0
0
26
154
1.70
1.77
1.7
1.4
—
—
—
0
0
61
440
1.41
1.75
1.5
1.6
3.01
10.82
u/ml
—
8
101
93
718
1.32
1.75
3.5
2.6
66.12
71.38
ml/min/173m2
0.64
43
282
987
9571
1.25
1.73
5.2
4.6
1.52
1.51
mmol/l
0.28
930
9032
109
863
1.29
1.72
3.5
4.9
1.80
1.77
mmol/l
0.03
98
748
5
13
3.86
1.71
1.4
1.1
—
—
—
0
0
46
317
1.47
1.69
1.9
2.1
1.55
1.47
g/l
0.23
41
281
21
119
1.78
1.67
1.4
1.4
—
—
—
0
0
21
119
1.78
1.67
1.4
1.4
—
—
—
0
0
22
127
1.75
1.65
2.5
1.7
—
—
—
0
0
34
221
1.56
1.64
2.4
2.5
—
—
—
0
0
33
213
1.57
1.64
4.2
3.1
3.09
1.84
ratio
0.31
23
113
21
120
1.76
1.63
1.4
1.4
—
—
—
0
0
40
578
0.68
1.61
1.5
1.5
64.12
61.03
ug/l
0.19
34
494
206
1766
1.20
1.60
2.2
2.2
—
—
—
0
0
30
191
1.59
1.58
1.2
1.1
—
—
—
0
0
134
1102
1.25
1.56
2.9
3.2
5.38
6.56
umol/l
0.93
111
952
17
93
1.84
1.52
1.1
1.2
46.29
81.61
u/l
0.71
17
86
7
27
2.60
1.51
1.3
1.2
—
—
—
0
0
36
243
1.50
1.48
1.3
1.4
290.65
218.46
u/ml
0.73
20
143
11
52
2.13
1.44
2.2
1.7
—
—
—
0
0
36
245
1.48
1.44
1.2
1.7
12.96
7.07
e6/l
0.25
23
176
31
205
1.53
1.41
1.6
1.6
12513.52
14791.25
e6/l
0.15
23
156
46
331
1.41
1.39
1.1
1.1
2.59
3.11
u/ml
0.12
31
178
13
67
1.95
1.38
2.7
1.8
—
—
—
0
0
35
239
1.48
1.38
1.3
1.3
—
—
—
0
0
6
23
2.62
1.37
1.0
1.2
—
—
—
0
0
36
248
1.47
1.36
2.3
1.7
—
—
—
0
0
37
523
0.70
1.36
1.5
1.5
—
—
—
0
0
120
992
1.23
1.36
2.2
1.9
—
—
—
0
0
36
249
1.46
1.34
1.2
1.7
54.33
178.29
e6/l
1.26
27
187
124
1030
1.23
1.34
2.1
1.8
—
—
—
0
0
9
42
2.15
1.34
1.0
1.2
—
—
—
0
0
10
48
2.09
1.28
1.9
1.7
75.66
95.33
ng/l
—
10
48
48
354
1.37
1.27
1.3
1.3
—
—
—
0
0
15
84
1.80
1.27
1.0
1.1
139.20
109.86
pmol/l
2.06
15
84
9
44
2.05
1.27
1.3
1.2
337.44
530.21
u/l
—
9
39
39
278
1.42
1.26
2.1
2.1
0.29
0.83
g/l
0.96
33
247
73
575
1.29
1.25
2.3
2.2
6.92
8.04
ug/l
0.29
63
513
119
993
1.22
1.24
4.4
4.0
20.71
21.85
%
0.40
59
426
79
629
1.28
1.24
1.3
1.4
—
—
—
0
0
8
37
2.17
1.21
1.9
1.0
—
—
—
0
0
20
124
1.62
1.21
1.5
1.4
—
—
—
0
0
14
79
1.78
1.17
1.1
1.1
302.64
294.96
mg/l
0.15
14
74
39
530
0.73
1.17
1.5
1.5
1.20
1.15
ratio
0.16
23
338
39
530
0.73
1.17
1.5
1.5
0.92
0.96
ratio
0.37
23
338
39
530
0.73
1.17
1.5
1.5
1.21
1.18
ratio
0.08
23
339
446
4151
1.12
1.13
2.0
1.9
1.36
1.34
mmol/l
0.16
373
3603
22
143
1.55
1.12
1.3
1.3
0.59
0.59
nmol/l
0.01
22
135
69
550
1.27
1.10
2.3
2.1
12.51
12.01
nmol/l
0.13
64
510
28
193
1.46
1.10
1.1
1.1
3.78
2.51
eliau/ml
0.25
11
91
20
128
1.57
1.09
2.7
1.8
—
—
—
0
0
281
2548
1.14
1.08
1.8
1.7
—
—
—
0
0
84
1017
0.81
1.06
1.5
1.6
1114.93
998.07
mu/l
0.62
75
866
10
52
1.93
1.06
3.0
1.6
—
—
—
0
0
50
386
1.31
1.03
1.6
1.5
16.20
9.11
u/l
1.45
39
316
144
1250
1.17
1.01
4.9
4.6
7.47
2.04
ug/l
0.54
131
1129
216
1936
1.14
0.99
2.3
2.3
—
—
—
0
0
151
1319
1.17
0.99
1.5
1.7
1.44
1.40
%
0.30
128
1190
26
181
1.45
0.99
2.6
1.8
—
—
—
0
0
96
806
1.21
0.98
2.8
4.4
4.07
15.30
ug/l
1.31
73
643
38
284
1.35
0.97
1.1
1.1
2.49
2.06
u/ml
0.13
24
150
42
319
1.33
0.97
1.7
1.9
—
—
—
0
0
10
54
1.86
0.96
3.0
1.6
—
—
—
0
0
12
69
1.75
0.96
1.5
1.1
—
—
—
0
0
504
4756
1.11
0.96
3.1
2.8
—
—
estimate
—
0
0
33
242
1.37
0.95
1.1
1.1
12.14
5.71
u/ml
0.60
19
126
39
294
1.34
0.95
1.8
1.8
—
—
—
0
0
6
27
2.23
0.93
1.3
2.0
25.32
99.93
u/l
—
6
27
6
27
2.23
0.93
2.2
1.4
—
—
—
0
0
40
305
1.32
0.91
1.2
1.1
3.62
4.31
—
5
47
25
176
1.43
0.91
1.4
1.5
—
—
—
0
0
120
1382
0.85
0.91
1.9
1.9
3.53
3.40
ratio
0.55
90
1057
21
143
1.48
0.90
1.2
1.1
—
0.55
—
0
8
6
29
2.07
0.89
1.8
1.6
—
—
—
0
0
40
307
1.31
0.88
6.1
7.3
1.23
1.32
mg/l
0.52
40
279
38
291
1.32
0.85
1.4
1.4
307.81
297.06
ug/g
0.11
17
170
6
31
1.94
0.84
1.2
1.1
0.46
26.22
u/ml
—
6
21
11
65
1.70
0.82
1.7
2.1
1.67
2.57
u/field
—
6
42
24
172
1.40
0.81
4.0
2.4
230.55
102.62
ug/min
0.35
18
108
87
740
1.19
0.81
2.7
2.9
0.60
0.74
ug/l
1.63
50
422
266
2450
1.11
0.80
2.4
2.3
—
—
—
0
0
63
521
1.22
0.78
3.4
4.9
2.08
1.78
mmol/l
0.32
50
378
18
123
1.47
0.78
1.2
1.1
—
—
—
0
0
32
243
1.33
0.77
1.8
1.8
0.00
0.00
g/l
-0.00
27
213
13
197
0.66
0.75
3.0
4.4
14.18
25.34
u/ml
1.41
13
192
91
1053
0.85
0.75
1.7
1.7
3.61
3.45
mmol/l
0.66
65
737
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
5
24
2.09
0.74
1.0
1.1
—
66.60
—
0
5
33
254
1.31
0.74
1.7
1.7
47.73
42.60
nmol/l
0.47
33
245
8
135
0.59
0.73
1.4
1.2
100.13
94.68
%
—
8
125
5
25
2.00
0.72
1.0
1.1
—
82.40
—
0
5
10
60
1.67
0.72
3.0
1.5
—
—
—
0
0
37
291
1.28
0.71
1.2
1.2
—
—
—
0
0
18
126
1.44
0.70
1.7
1.6
—
—
—
0
0
7
41
1.71
0.70
1.0
1.0
—
—
—
0
0
29
224
1.30
0.65
1.1
1.1
12.56
7.13
u/ml
0.55
17
104
37
296
1.26
0.64
1.1
1.1
10.35
4.70
u/ml
0.72
25
171
14
95
1.48
0.64
1.8
1.7
—
—
—
0
0
84
730
1.16
0.64
2.6
2.3
3749.05
5833.56
u/l
0.41
24
324
5
29
1.73
0.64
1.0
1.9
36.12
42.23
g/l
—
5
29
25
190
1.32
0.63
2.0
1.3
4.73
3.95
u/ml
0.12
11
77
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
50
1.60
0.61
1.1
1.1
—
—
—
0
0
8
50
1.60
0.61
1.1
1.2
16.50
17.45
u/l
—
8
42
8
52
1.54
0.59
1.1
1.2
98.13
88.09
u/l
—
8
45
59
502
1.19
0.59
1.3
1.3
208.75
248.67
miu/ml
0.49
31
251
6
36
1.67
0.56
1.5
1.4
—
—
—
0
0
35
284
1.24
0.56
1.1
1.1
0.70
1.36
u/ml
0.64
19
128
14
99
1.42
0.54
1.0
1.2
31.95
29.96
mg/l
—
8
77
11
74
1.49
0.53
2.4
2.1
—
—
—
0
0
13
91
1.43
0.53
1.1
1.1
—
—
—
0
0
35
288
1.22
0.50
1.2
1.2
—
—
—
0
0
60
520
1.16
0.50
1.7
1.5
—
—
—
0
0
10
67
1.50
0.49
1.0
1.3
—
—
—
0
0
26
208
1.26
0.48
1.0
1.1
0.13
0.27
u/ml
0.42
13
66
7
49
1.43
0.46
1.1
1.1
—
—
—
0
0
29
238
1.22
0.44
2.9
2.8
4.86
2.05
index
0.34
14
115
140
1293
1.09
0.44
2.8
2.1
—
—
—
0
0
867
8530
1.07
0.43
21.3
16.6
13.45
13.44
%
0.15
859
8422
11
78
1.41
0.43
1.6
1.5
—
—
—
0
0
11
78
1.41
0.43
1.6
1.5
—
—
—
0
0
11
78
1.41
0.43
1.6
1.5
—
—
—
0
0
5
31
1.62
0.43
1.0
1.2
—
—
—
0
0
8
56
1.43
0.42
2.3
1.6
—
1224680.00
—
0
5
44
379
1.17
0.41
1.4
1.5
62.34
57.73
ug/l
0.24
44
379
8
59
1.36
0.41
1.1
1.2
14.25
8.39
mm/h
—
8
59
5
34
1.47
0.40
1.0
1.0
—
—
—
0
0
5
35
1.43
0.39
3.4
2.3
12.98
17.60
umol/l
—
5
35
10
71
1.41
0.39
2.0
1.5
—
—
—
0
0
64
571
1.13
0.38
3.3
5.2
24.10
24.16
mmol/l
0.06
64
565
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
24
197
1.22
0.38
3.0
7.0
0.45
0.40
iu/ml
0.14
12
108
5
77
0.65
0.35
1.2
1.4
—
—
—
0
0
250
2386
1.06
0.35
4.5
4.2
94.80
94.38
%
0.10
241
2336
12
91
1.32
0.34
1.1
1.1
—
—
—
0
0
115
1069
1.08
0.33
2.6
1.9
—
—
—
0
0
6
46
1.31
0.33
3.7
3.1
0.67
0.83
index
—
6
46
87
800
1.09
0.32
1.4
1.4
20.34
25.07
iu/l
0.85
74
677
59
653
0.90
0.32
1.6
1.5
—
—
—
0
0
49
437
1.13
0.31
1.9
1.8
—
—
—
0
0
7
96
0.73
0.31
1.3
1.6
—
1215.90
—
0
13
53
476
1.12
0.30
10.9
11.1
24.50
24.31
mmol/l
0.15
53
467
170
1611
1.07
0.30
2.7
2.8
0.64
1.09
e6/l
3.66
101
815
10
75
1.34
0.30
1.5
1.3
72.50
72.79
umol/l
—
10
75
14
111
1.26
0.30
1.1
1.1
—
—
—
0
0
34
299
1.14
0.27
1.9
3.1
17.38
893.66
u/ml
1.18
29
260
13
104
1.25
0.26
2.3
2.7
27.31
23.74
nmol/l
0.29
13
98
155
1476
1.06
0.25
2.7
3.0
4.48
4.02
e6/l
0.15
86
686
43
476
0.90
0.25
1.1
1.1
1.56
1.56
g/l
0.01
43
476
173
1655
1.05
0.24
4.2
3.4
945.75
452.42
ng/l
0.44
120
1097
10
125
0.80
0.23
1.0
1.1
—
—
—
0
0
5
40
1.25
0.22
1.4
1.1
36.84
52.68
u/ml
—
5
40
0
11
0.00
0.21
0.0
1.9
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.8
—
—
—
0
0
29
259
1.12
0.20
1.4
1.5
0.41
0.42
nmol/l
0.06
23
216
0
14
0.00
0.20
0.0
2.9
—
0.86
—
0
14
6
48
1.25
0.20
1.3
1.3
96.17
170.85
pmol/l
—
6
48
6
48
1.25
0.20
1.0
1.1
169.13
181.55
iu/ml
—
6
48
44
478
0.92
0.19
1.8
1.9
2.55
4.65
mg/l
0.88
29
342
22
194
1.14
0.18
2.6
1.8
—
—
—
0
0
19
166
1.15
0.18
1.3
1.4
—
—
—
0
0
19
166
1.15
0.18
1.3
1.4
—
—
—
0
0
22
195
1.13
0.17
1.5
1.3
—
—
—
0
0
29
264
1.10
0.15
1.3
1.2
—
—
—
0
0
9
79
1.14
0.15
6.6
3.5
—
—
—
0
0
71
674
1.06
0.15
2.5
2.9
87.39
69.10
u/ml
0.10
71
654
46
487
0.94
0.12
1.2
1.2
0.87
0.88
g/l
0.14
46
487
46
487
0.94
0.12
1.5
1.7
—
—
—
0
0
51
484
1.06
0.11
1.5
1.6
—
—
—
0
0
11
96
1.15
0.10
1.4
1.2
—
—
—
0
0
5
46
1.09
0.09
1.6
1.3
—
—
—
0
0
11
97
1.14
0.09
1.4
1.2
—
—
—
0
0
5
64
0.78
0.08
1.6
1.6
0.48
0.48
e9/l
—
5
64
7
68
1.03
0.08
1.9
1.2
—
—
—
0
0
43
449
0.96
0.07
1.1
1.1
0.69
0.62
ratio
—
6
52
95
926
1.03
0.07
2.8
2.4
34.91
90.62
u/l
0.53
87
769
8
76
1.05
0.07
1.6
1.3
—
—
—
0
0
20
186
1.08
0.07
2.3
1.2
1.43
4.74
u/ml
—
7
65
20
186
1.08
0.07
1.2
1.1
—
—
—
0
0
10
89
1.12
0.07
1.2
1.0
—
—
—
0
0
40
416
0.96
0.06
1.2
1.4
—
—
—
0
0
13
119
1.09
0.06
1.2
1.2
—
—
—
0
0
55
565
0.97
0.05
1.7
1.6
290.32
295.62
mu/l
0.05
50
503
27
280
0.96
0.03
1.3
1.3
—
—
—
0
0
11
102
1.08
0.03
1.3
1.2
20.32
14.21
u/ml
—
5
45
67
681
0.98
0.02
1.0
1.1
—
—
—
0
0
32
311
1.03
0.02
1.2
1.5
99.37
200.46
pmol/l
0.94
32
304
48
487
0.98
0.01
1.4
1.6
0.27
0.32
mg/l
0.27
20
215
11
112
0.98
0.00
2.1
2.2
—
—
—
0
0
23
231
1.00
0.00
1.8
1.5
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
2.80
—
0
5
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
627.40
—
0
5
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
9.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
7
71
0.99
-0.00
2.0
1.5
—
—
—
0
0
5
51
0.98
-0.00
2.2
1.8
1.00
1.90
u/field
—
5
41
0
9
0.00
-0.00
0.0
3.3
—
8.10
—
0
9
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
4.9
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint L12_ALOPECAREATA and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| L12_ALOPECAREATA | 1.002 [0.85, 1.18] | 0.981 |
| Birth year | 0.996 [0.99, 1.0] | 0.338 |
During the follow-up period (1.1.1998 — 31.12.2019), 192 out of 4322 females with L12_ALOPECAREATA died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| L12_ALOPECAREATA | 0.868 [0.7, 1.08] | 0.206 |
| Birth year | 0.987 [0.98, 1.0] | 0.007 |
During the follow-up period (1.1.1998 — 31.12.2019), 93 out of 1847 males with L12_ALOPECAREATA died.
Mortality risk
Mortality risk for people of age
years, who have L12_ALOPECAREATA.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.093% | 0.179% |
| 5 | 0.573% | 1.007% |
| 10 | 1.445% | 2.59% |
| 15 | 2.937% | 4.999% |
| 20 | 5.217% | 8.461% |
Relationships between endpoints
↥Index endpoint: L12_ALOPECAREATA – Alopecia areata
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data